NORGALAX, rectal gel in a single-dose container 6 single-dose containers of 10 g
Active ingredients: Docusate sodium
Commercialized according to BDPM
Gel6 single-dose containers of 10 grectale
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- NORGALAX, gel rectal en récipient unidose
- Pharmaceutical form
- gel
- Route of administration
- rectale
- Presentation description
- 6 récipient(s) unidose(s) polyéthylène basse densité (PEBD) avec canule(s) polyéthylène de 10 g
- Marketing authorisation holder
- ESSENTIAL PHARMA (M) (MALTE)
- Reimbursement according to BDPM
- —
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 19 Mar 1985
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
69281980CIP73269116CIP133400932691166Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| DOCUSATE DE SODIUMgel | 0,12 g · un récipient unidose | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.